News

Adjupanrix, a pandemic influenza vaccine (split virion, inactivated, adjuvanted) manufactured by GSK, has been reserved for future manufacturing and supply under a framework agreement with the European Commission's (EC) Health Emergency Preparedness and Response Authority (HERA). Influenza pandemics, which are caused...

A third workplan with measures due by 2025 has been released by the joint Big Data Steering Group of the European Medicines Agency (EMA) as well as the Heads of Medicines Agencies (HMA). The new strategy, according to EMA, will...

Indian pharmaceutical exports increased by 8% in the first quarter of the current fiscal year to $6.26 billion, with officials anticipating a 10% increase by year's end. Pharma exports to the European Union and other CIS countries, which were affected...

Adenine base editors were successfully created by GenKOre, a biotech startup in South Korea, using its unique hypercompact gene-editing method. The hypercompact ABEs created by GenKOre are distinguished by their small size, ability to be delivered via an adeno-associated virus...

Following NICE's recommendation of a novel therapy alternative for diabetic macular oedema (DMO), thousands of patients could receive transformative care. In the final form of the guidance, brolucizumab, also known as Beovu, is suggested as a treatment for adults...

Could the Senate adopt a "watershed" bill allowing drug price discussions after years of government inaction regarding medication prices in the U.S.? Analysts are busy studying the information at hand to determine how the legislation would impact the leading companies...

Positive top-line statistics from Cyclerion Therapeutics' clinical investigation of CY6463 for the treatment of cognitive impairment associated with schizophrenia have been released. It concerns people with stable schizophrenia who are taking a stable dose of a single atypical antipsychotic...